Anhui Anke Biotechnology (Group) Co., Ltd. - Laporan Laba Rugi (TTM)

Anhui Anke Biotechnology (Group) Co., Ltd.
CN ˙ SZSE ˙ CNE100000GY2
CN¥ 11.14 ↑0.10 (0.91%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Anhui Anke Biotechnology (Group) Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2023
01-01
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 1,702 1,701 1,871 1,959 2,096 2,169 2,217 2,280 2,328 2,331 2,392 2,538 2,646 2,866 2,928 2,877 2,766 2,536 2,509 2,529
Change (%) -0.03 9.96 4.69 7.03 3.45 2.24 2.84 2.10 0.13 2.61 6.09 4.26 8.31 2.16 -1.72 -3.88 -8.30 -1.08 0.83
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 372 364 391 404 423 436 450 467 494 513 556 585 609 626 628 621 613 581 578 606
Change (%) -2.24 7.29 3.54 4.55 3.14 3.12 3.79 5.80 3.97 8.29 5.24 4.03 2.86 0.22 -1.04 -1.24 -5.24 -0.54 4.79
% of Revenue 21.88 21.40 20.88 20.65 20.17 20.11 20.28 20.47 21.21 22.03 23.25 23.06 23.01 21.85 21.43 21.58 22.17 22.92 23.04 23.95
Gross Operating Profit 1,330 1,337 1,480 1,554 1,674 1,733 1,768 1,813 1,834 1,818 1,836 1,952 2,037 2,240 2,300 2,256 2,152 1,955 1,931 1,924
Change (%) 0.59 10.69 4.99 7.68 3.53 2.02 2.60 1.14 -0.90 1.00 6.35 4.33 9.94 2.70 -1.91 -4.61 -9.18 -1.24 -0.36
% of Revenue 78.12 78.60 79.12 79.35 79.83 79.89 79.72 79.53 78.79 77.97 76.75 76.94 76.99 78.15 78.57 78.42 77.83 77.08 76.96 76.05
SG&A 781 795 867 900 944 947 941 911 862 877 861 904 954 1,055 1,083 1,089 1,092 994 984 1,000
Change (%) 1.80 8.97 3.85 4.86 0.35 -0.65 -3.16 -5.39 1.66 -1.82 4.99 5.57 10.58 2.68 0.56 0.23 -8.96 -1.01 1.67
% of Revenue 45.92 46.75 46.33 45.96 45.03 43.68 42.44 39.97 37.04 37.60 35.98 35.60 36.05 36.81 36.99 37.85 39.47 39.19 39.22 39.54
R&D 117 129 142 134 154 167 163 168 174 166 172 207 211 255 256 235 230 201 198 216
Change (%) 9.89 10.54 -5.58 14.42 8.30 -2.21 3.20 3.39 -4.46 3.84 20.11 1.91 20.69 0.71 -8.32 -2.05 -12.60 -1.62 8.94
% of Revenue 6.88 7.57 7.61 6.86 7.34 7.68 7.34 7.37 7.46 7.12 7.21 8.16 7.98 8.89 8.76 8.17 8.33 7.94 7.89 8.53
OpEx 1,251 1,305 1,424 1,467 1,553 1,569 1,564 1,550 1,531 1,575 1,618 1,736 1,815 1,953 1,981 1,944 1,936 1,777 1,757 1,839
Change (%) 4.30 9.10 3.06 5.83 1.08 -0.37 -0.88 -1.19 2.87 2.71 7.27 4.55 7.62 1.45 -1.90 -0.37 -8.25 -1.12 4.68
% of Revenue 73.50 76.68 76.09 74.91 74.06 72.37 70.52 67.97 65.78 67.58 67.65 68.40 68.58 68.14 67.67 67.55 70.02 70.05 70.02 72.70
Operating Income 451 397 447 492 544 599 654 730 797 756 774 802 831 913 947 934 829 759 752 691
Change (%) -12.03 12.79 9.86 10.63 10.22 9.08 11.73 9.06 -5.13 2.40 3.63 3.65 9.83 3.68 -1.35 -11.19 -8.41 -0.97 -8.18
% of Revenue 26.50 23.32 23.91 25.09 25.94 27.63 29.48 32.03 34.22 32.42 32.35 31.60 31.42 31.86 32.33 32.45 29.98 29.95 29.98 27.30
Interest Expense -2 -2 -2 -2 -2 -2 -2 -2 -1 -2 -2 -2 -4 -2 -2 -3 -3 -2 -2 -2
Change (%) 1.49 5.76 -10.21 -0.40 5.96 -3.67 -3.74 -2.10 3.32 2.97 4.24 154.67 -54.96 26.98 6.75 7.08 -11.59 -12.47 0.91
% of Revenue -0.09 -0.10 -0.09 -0.08 -0.07 -0.07 -0.07 -0.07 -0.06 -0.07 -0.07 -0.06 -0.16 -0.07 -0.08 -0.09 -0.10 -0.09 -0.08 -0.08
Net Income 167 359 403 441 489 207 254 307 372 703 716 755 763 847 879 867 783 707 698 657
Change (%) 115.47 12.31 9.29 11.05 -57.77 22.90 20.92 20.99 89.28 1.81 5.47 1.09 10.98 3.79 -1.41 -9.74 -9.66 -1.24 -5.85
% of Revenue 9.79 21.10 21.55 22.49 23.34 9.53 11.45 13.47 15.96 30.17 29.93 29.76 28.85 29.56 30.04 30.13 28.29 27.88 27.83 25.99

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista